Paragon Care (ASX:PGC) Shares Confront Statutory Loss And Infinity Risk

Simply Wall St.

Aug 27

Paragon Care stock barely flinched into the FY26 result, closing at A$0.135 after flat short term returns and a weak 90 day run. The headline story is not the share price. It is the split between a ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/2662370766"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2662370766\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2662370766?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307","is_english":true,"pubTime":"2026-08-27 19:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2662370766","market":"sg","top_or_hot":-1,"title":"Paragon Care (ASX:PGC) Shares Confront Statutory Loss And Infinity Risk","media":"Simply Wall St.","content":"<div>\n<p>Paragon Care stock barely flinched into the FY26 result, closing at A$0.135 after flat short term returns and a weak 90 day run. The headline story is not the share price. It is the split between a ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-pgc/paragon-care-shares/news/paragon-care-asxpgc-shares-confront-statutory-loss-and-infin\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Paragon Care (ASX:PGC) Shares Confront Statutory Loss And Infinity Risk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nParagon Care (ASX:PGC) Shares Confront Statutory Loss And Infinity Risk\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-27 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/healthcare/asx-pgc/paragon-care-shares/news/paragon-care-asxpgc-shares-confront-statutory-loss-and-infin><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Paragon Care stock barely flinched into the FY26 result, closing at A$0.135 after flat short term returns and a weak 90 day run. The headline story is not the share price. It is the split between a ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-pgc/paragon-care-shares/news/paragon-care-asxpgc-shares-confront-statutory-loss-and-infin\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7103","symbol_name":"保健护理产品经销商","start_time":0,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pgc/paragon-care-shares/news/paragon-care-asxpgc-shares-confront-statutory-loss-and-infin","article_id":"2662370766","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pgc/paragon-care-shares/news/paragon-care-asxpgc-shares-confront-statutory-loss-and-infin","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2662370766","pubTimestamp":1787830361,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Paragon Care stock barely flinched into the FY26 result, closing at A$0.135 after flat short term returns and a weak 90 day run. The headline story is not the share price. It is the split between a solid underlying profit picture and a statutory loss driven by the Infinity provisioning hit. Underlying net profit after tax of A$26m sits in sharp contrast to a statutory net loss of A$16m, which keeps the investment debate firmly on balance sheet strain and how much flexibility the company...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7103":"保健护理产品经销商","PGC":"皮帕克格拉德斯通金融","BK4211":"区域性银行","PGC.AU":"PARAGON CARE LTD"},"translate_title":"Paragon Care (ASX:PGC) 股票面临法定损失和无限风险","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PGC":1.5,"PGC.AU":1.5},"content_text":"Paragon Care stock barely flinched into the FY26 result, closing at A$0.135 after flat short term returns and a weak 90 day run. The headline story is not the share price. It is the split between a solid underlying profit picture and a statutory loss driven by the Infinity provisioning hit. Underlying net profit after tax of A$26m sits in sharp contrast to a statutory net loss of A$16m, which keeps the investment debate firmly on balance sheet strain and how much flexibility the company really has from here. Is Paragon Care a genuine bargain on a low 0.1x P/S, or is the widening loss profile a warning that the market is pricing in more pain? Compare that gap directly in the valuation analysis for Paragon Care AdvertisementFY 2026 Earnings Summary  Revenue (FY 2026 vs FY 2025): A$3.68b vs A$3.61b (reported growth of about 1.8% on an underlying organic basis and 6.7% after management normalisations for Infinity, Ramsay exit and FX) Net Income or Loss (FY 2026 vs FY 2025): Underlying NPAT A$26.0m vs earnings from continuing operations of A$20.6m. Statutory net loss of A$16.0m for FY 2026, mainly linked to the Infinity provision Basic EPS (FY 2026 vs FY 2025): Trailing twelve month basic EPS of a loss of A$0.0097 vs earnings of A$0.0124 in the prior trailing period. Half year 2 FY 2026 basic EPS of A$0.00318 vs A$0.00444 in half year 2 FY 2025 EBITDA (FY 2026 vs FY 2025): Underlying EBITDA of A$97.2m vs statutory EBITDA of A$50.8m in FY 2026, showing a large gap between core trading performance and reported results after provisions and adjustments  Prefer clean charts instead of another wall of dense earnings text? See Paragon Care’s full visual breakdown, including its balance sheet strength and funding flexibility, in the latest company report for Paragon Care. ASX:PGC Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026 Paragon Care’s Bull Story Hinges On Execution Milestones The bullish view on Paragon Care hinges on a cleaner, higher margin healthcare platform driven by Asia MedTech growth, GLP drug demand and contract logistics scale. The FY26 numbers show parts of that script playing out. Medical technology delivered double digit growth, with Asia described as very strong and Thailand aesthetics contributing despite early stage margin dilution. That aligns with the claim that Asia MedTech can become a more meaningful earnings driver. On the logistics side, the new Brisbane distribution centre is fully operational and offsite storage and express transfers remain elevated for now. Management expects those costs to ease as the site is utilised. Contract logistics delivered strong revenue and margin growth with a healthy pipeline, and the multiyear Owens & Minor and QuidelOrtho contracts are in place. These are tangible milestones that support the idea of a more scalable, integrated platform, even while statutory results are weighed down by Infinity. Reveal whether this operational progress at Paragon Care lines up with institutional expectations and recent price action, and see how analysts are framing the risk and reward skew at A$0.135 with the consensus price target analysis for Paragon Care. Paragon Care Bear Case Focuses On Balance Sheet Strain The bearish story on Paragon Care is that Infinity, leverage and heavy integration spend will choke balance sheet flexibility and delay any real earnings quality. The FY26 print gives that argument some backing. A statutory net loss of A$16m, despite A$26m of underlying NPAT and A$97.2m of underlying EBITDA, shows how reliant the story still is on adjustments. The Infinity provision sits at A$38m after a A$9.2m write back, so recovery risk is far from closed out. Bears also worry that integration and the Willawong and Brisbane distribution build keep costs sticky. Management confirms capex has just peaked and offsite storage and express transfers remain elevated. Net debt is around 2.5x EBITDA, and the decision to withhold a dividend while talking about a potential buyback in FY27 supports the view that capital allocation is tight and milestones on clean cash generation are not yet met. After interest cover concerns, Infinity risk and leverage, are these issues isolated or early signals of deeper structural fragility? Review our risk analysis for Paragon Care which shows 1 important warning sign. Stay Ahead Of Your Next Move If the split between Paragon Care’s underlying earnings and statutory loss has your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch how the Infinity impact and balance sheet story evolve. When you do hold Paragon Care or other stocks, use the Portfolio Command Center to cut through noise and focus on the most important updates for your positions. For a longer term view, tap into the Community to see how other investors are thinking about similar risks and catalysts. This can help you identify potential turning points and hidden issues early, and stay ahead of the broader market. Seeking Alternatives Beyond Paragon Care? Fresh ideas move fast. Breakout themes, early momentum and stocks still flying under the radar for now can get caught by the crowd quickly, so do not delay and act now.  Spot cash rich compounders before momentum headlines catch up by scanning a curated list of solid balance sheet and fundamentals stocks (22 results) while the best candidates are still quietly priced in. Target future facing infrastructure as AI demand builds by reviewing hand picked 55 AI infrastructure stocks that support data centers, chips and high intensity computing capacity. Ride potential yield and price stability together by checking carefully filtered 8 dividend fortresses before income focused investors crowd into the same opportunities.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}